Phase 3 Deep Vein Thrombosis Clinical Trials

2 recruitingPhase 3

What is a Phase 3 trial?

Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.

Showing 1–2 of 2 trials

Recruiting

Phase 3

RIVAroxaban Versus Low-molecular Weight Heparin in Patients With Lower Limb Trauma Requiring Brace or CASTing

Venous ThromboembolismPulmonary EmbolismDeep Vein Thrombosis+3 more

University Hospital, Angers1,424 enrolled35 locationsNCT06195540

Completed

Phase 3Phase 4

Assessment of microbleeding after prophylaxis with enoxaparin or rivaroxaban against venous thromboembolic disease following hip and knee surgery

Prevention and treatment of venous thromboembolism (VTE); comprising deep vein thrombosis (DVT) and pulmonary embolism (PE) after hip and knee arthroplasty.

Launceston General Hospital1,060 enrolled1 locationACTRN12609000762257